Hutch News

Pretargeting redux: A bispecific antibody re-ignites radioimmunotherapy

Pretargeting redux: A bispecific antibody re-ignites radioimmunotherapy

From the Green lab, Clinical Research Division
Science SpotlightJanuary 15, 2018
One family, two sides of cancer

One family, two sides of cancer

Basic scientist Dr. Wenying Shou’s parents were both treated for — and cured of — their cancers. The similarities end there.
Hutch NewsOctober 06, 2017
Good News at Fred Hutch

Good News at Fred Hutch

Celebrating faculty and staff achievements, and other notable news
Hutch NewsDecember 18, 2015